Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

JW Holdings Corporation

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Drug Manufacturers - Specialty & GenericSector: Healthcare

Fair Value Summary

Current Price$3,805.00
5Y Range32,909.32 – 79,289.14
5Y Selected56,099.23
(-) Safety Margin77.22%
5Y Buy Price$14,552.14
Upside (to Buy Price)282.45%
10Y Range35,168.11 – 81,867.28
10Y Selected58,517.70
(-) Safety Margin77.22%
10Y Buy Price$15,179.49
Upside (to Buy Price)298.94%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.7653
Revenue R2 (10Y)0.9417
Net Income R2 (5Y)0.6811
Net Income R2 (10Y)0.1311
EBITDA R2 (5Y)0.7605
EBITDA R2 (10Y)0.6819
FCF R2 (5Y)0.0252
FCF R2 (10Y)0.1456
Safety Score0.2594

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth4.76%4.68%4.59%4.51%4.42%4.34%4.25%4.17%4.08%4.00%
Revenue929,985.43973,486.421,018,197.671,064,100.041,111,170.501,159,381.961,208,703.221,259,098.891,310,529.301,362,950.47
EBITDA239,857.85251,077.44262,609.17274,448.11286,588.32299,022.81311,743.54324,741.38338,006.09351,526.33
D&A-43,519.58-45,555.25-47,647.55-49,795.60-51,998.31-54,254.41-56,562.45-58,920.76-61,327.50-63,780.60
EBIT196,338.27205,522.19214,961.61224,652.51234,590.01244,768.40255,181.10265,820.61276,678.59287,745.73
Pro forma Taxes-86,980.01-91,048.58-95,230.35-99,523.53-103,925.95-108,435.09-113,048.03-117,761.45-122,571.65-127,474.52
NOPAT109,358.26114,473.60119,731.26125,128.98130,664.06136,333.31142,133.07148,059.17154,106.94160,271.22
Capital Expenditures-48,206.93-50,461.86-52,779.52-55,158.93-57,598.88-60,097.98-62,654.61-65,266.93-67,932.89-70,650.21
NWC Investment-6,647.83-6,840.55-7,030.87-7,218.17-7,401.85-7,581.28-7,755.79-7,924.75-8,087.46-8,243.26
(+) D&A43,519.5845,555.2547,647.5549,795.6051,998.3154,254.4156,562.4558,920.7661,327.5063,780.60
Free Cash Flow98,023.08102,726.44107,568.42112,547.48117,661.63122,908.46128,285.11133,788.25139,414.09145,158.35
Diluted Shares Outstanding70,250,250.0070,250,250.0070,250,250.0070,250,250.0070,250,250.0070,250,250.0070,250,250.0070,250,250.0070,250,250.0070,250,250.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 6.53%Terminal Growth: 3.09%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.910.860.800.750.710.660.620.59
PV UFCF97,405.1199,781.0098,080.8896,331.7194,537.1092,700.7290,826.2888,917.4886,978.0785,011.77
Raw: 3,526,036.32
2,744,865.96
Raw: 4,350,046.80
2,468,299.94

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value3,231,001.743,398,870.04
(-) Net Debt245.75245.75
Equity Value3,230,755.993,398,624.30
(/) Shares Out70.2570.25
Fair Value$45,989.25$48,378.82
(-) Safety Margin77.22%77.22%
Buy Price$10,476.35$11,020.70
Current Price$3,805.00$3,805.00
Upside (to Buy Price)175.33%189.64%

Conservative Projected Flows

WACC: 7.53%Terminal Growth: 2.59%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.900.840.780.720.670.630.580.54
PV UFCF97,314.1499,353.0696,752.0194,142.8091,529.7788,917.1386,309.0083,709.3481,122.0278,550.74
Raw: 2,443,468.68
1,833,041.74
Raw: 3,014,490.53
1,573,114.30

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value2,312,133.522,470,814.33
(-) Net Debt245.75245.75
Equity Value2,311,887.782,470,568.58
(/) Shares Out70.2570.25
Fair Value$32,909.32$35,168.11
(-) Safety Margin77.22%77.22%
Buy Price$7,496.74$8,011.30
Current Price$3,805.00$3,805.00
Upside (to Buy Price)97.02%110.55%

Aggressive Projected Flows

WACC: 5.53%Terminal Growth: 3.59%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.980.920.880.830.790.750.710.670.63
PV UFCF97,497.02100,214.8399,440.7998,592.8797,673.0196,683.3095,625.9894,503.4493,318.1892,072.85
Raw: 6,282,676.72
5,076,909.33
Raw: 7,750,895.12
4,785,820.67

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value5,570,327.865,751,442.95
(-) Net Debt245.75245.75
Equity Value5,570,082.115,751,197.20
(/) Shares Out70.2570.25
Fair Value$79,289.14$81,867.28
(-) Safety Margin77.22%77.22%
Buy Price$18,062.07$18,649.37
Current Price$3,805.00$3,805.00
Upside (to Buy Price)374.69%390.13%

Reverse DCF: Market Implied Growth

Current Price$3,805.00
WACC Used6.5%
IMPLIED REVENUE GROWTH70.10%
Metric2027202820292030203120322033203420352036
Implied Revenue1,591,285.782,706,759.254,604,167.087,831,636.5013,321,525.7422,659,765.6838,544,006.9465,562,922.94111,521,795.62189,697,321.90
Constant Implied Growth70.10%70.10%70.10%70.10%70.10%70.10%70.10%70.10%70.10%70.10%
Implied Free Cash Flow159.13270.68460.42783.161,332.152,265.983,854.406,556.2911,152.1818,969.73
Discount Factor0.950.860.800.750.710.660.620.590.550.52
Present Value of Implied FCF150.99231.68369.93590.68943.171,506.002,404.693,839.686,130.999,789.63

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$5,697.194.27%$10,995.8593.00%
20182018-12-31$6,262.946.86%$41,252.00558.67%
20172017-12-31$7,190.544.45%$-13,651.14-289.85%
20162016-12-31$7,292.343.54%$-20,315.03-378.58%
20152015-12-31$7,367.702.03%$-17,504.65-337.59%
20142014-12-31$1,949.452.51%$-18,133.75-1,030.20%
20132013-12-31$1,942.614.45%$-29,790.12-1,633.51%
20122012-12-31$1,708.654.51%$-20,198.15-1,282.11%
20112011-12-31$1,698.194.84%$-41,907.65-2,567.78%
20102010-12-31$1,789.842.73%$-19,934.92-1,213.78%
20092009-12-31$1,340.031.14%$-26,743.27-2,095.72%
20082008-12-31$671.20-1.96%$-15,259.09-2,373.40%
20072007-12-31$1,758.46-2.15%$-8,215.17-567.18%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$57,052.09
Median
$47,998.42
10th Percentile
$35,483.92
90th Percentile
$80,848.46

Fair Value Distribution

$25,498.84 - $110,783.13
965
$110,783.13 - $196,067.42
26
$196,067.42 - $281,351.72
5
$281,351.72 - $366,636.01
2
$366,636.01 - $451,920.30
0
$451,920.30 - $537,204.59
0
$537,204.59 - $622,488.88
1
$622,488.88 - $707,773.17
0
$707,773.17 - $793,057.47
0
$793,057.47 - $878,341.76
0
$878,341.76 - $963,626.05
0
$963,626.05 - $1,048,910.34
0
$1,048,910.34 - $1,134,194.63
0
$1,134,194.63 - $1,219,478.93
0
$1,219,478.93 - $1,304,763.22
0
$1,304,763.22 - $1,390,047.51
0
$1,390,047.51 - $1,475,331.80
0
$1,475,331.80 - $1,560,616.09
0
$1,560,616.09 - $1,645,900.38
0
$1,645,900.38 - $1,731,184.68
1